Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients

被引:0
|
作者
Baroncini, D.
Ghezzi, A.
Rocca, M. A.
Annovazzi, P. O.
Bianchi, A.
Minonzio, G.
Zaffaroni, M.
Filippi, M.
Comi, G.
机构
[1] Ctr Studi Sclerosi Multipla, Gallarate, Italy
[2] Hosp San Raffaele, I-20132 Milan, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:219 / 220
页数:2
相关论文
共 50 条
  • [42] Fingolimod reduces the risk of recurrence of disease activity during the first 12 months after natalizumab discontinuation in multiple sclerosis
    Havla, J.
    Tackenberg, B.
    Hellwig, K.
    Meinl, I.
    Krumbholz, M.
    Seitz, F.
    Eienbroecker, C.
    Gold, R.
    Hohlfeld, R.
    Kleiter, I.
    Kuempfel, T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 230 - 231
  • [43] A case of early disease rebound after fingolimod discontinuation in a patient with multiple sclerosis and SARS-CoV-2 infection
    Giovannini, Beatrice
    Panelli, Deborah
    Bianchi, Francesca
    Siciliano, Gabriele
    Pasquali, Livia
    NEUROLOGICAL SCIENCES, 2024, 45 (06) : 2423 - 2426
  • [44] A case of early disease rebound after fingolimod discontinuation in a patient with multiple sclerosis and SARS-CoV-2 infection
    Beatrice Giovannini
    Deborah Panelli
    Francesca Bianchi
    Gabriele Siciliano
    Livia Pasquali
    Neurological Sciences, 2024, 45 : 2423 - 2426
  • [45] Incidence of recurrence of disease activity after fingolimod discontinuation in older patients
    Pantazou, V.
    Pot, C.
    Le Goff, G.
    Du Pasquier, R.
    Theaudin, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 162 - 163
  • [46] Neurovascular reactivity after Fingolimod treatment in patients with multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 917 - 918
  • [47] Rebound Syndrome in Multiple Sclerosis Patients After Cessation of Fingolimod
    Hatcher, Stacy
    Waubant, Emmanuelle
    Nourbakhsh, Bardia
    Crabtree-Hartman, Elizabeth
    Graves, Jennifer
    NEUROLOGY, 2016, 86
  • [48] Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
    Alping, Peter
    Frisell, Thomas
    Novakova, Lenka
    Islam-Jakobsson, Protik
    Salzer, Jonatan
    Bjorck, Anna
    Axelsson, Markus
    Malmestrom, Clas
    Fink, Katharina
    Lycke, Jan
    Svenningsson, Anders
    Piehl, Fredrik
    ANNALS OF NEUROLOGY, 2016, 79 (06) : 950 - 958
  • [49] Rebound syndrome in multiple sclerosis patients after cessation of fingolimod
    Hatcher, Stacy E.
    Waubant, Emmanuelle
    Nourbakhsh, Bardia
    Crabtree-Hartmann, Elizabeth
    Graves, Jennifer S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 25 - 25
  • [50] Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuation
    Zecca, C.
    Antozzi, C. G.
    Clerici, V. Torri
    Ferrazzini, M.
    Mantegazza, R. E.
    Rossi, S.
    Gobbi, C.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 137 (06): : 623 - 625